Teva joins medical cannabis market with Israel distribution deal
Under the agreement announced Friday, S.L.E. will distribute Canndoc's GMP-approved products to clients in Israel, including hospitals, health maintenance organizations (HMOs) and all pharmacies.
Employee tends to medical cannabis plants at Pharmocann, an Israeli medical cannabis company in northern Israel(photo credit: AMIR COHEN/REUTERS)ByEYTAN HALON